Corbus Pharmaceuticals

$0.00 (0.00%) Today
-$0.01 (-0.46%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRBP and other stocks, options, and ETFs commission-free!

About CRBP

Corbus Pharmaceuticals Holdings, Inc. Common Stock, also called Corbus Pharmaceuticals, is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.

CEO
Yuval Cohen
Employees
76
Headquarters
Norwood, Massachusetts
Founded
2009

CRBP Key Statistics

Market Cap
274.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.80M
High Today
$2.20
Low Today
$2.14
Open Price
$2.17
Volume
918.30K
52 Week High
$9.78
52 Week Low
$0.91

CRBP Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure